MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis, in vitro study, and docking calculations

作者: G. L. Delogu , F. Pintus , L. Mayán , M. J. Matos , S. Vilar

DOI: 10.1039/C7MD00311K

关键词: SubstituentMonoamine neurotransmitterChemistryBiochemistryBenzofuranDocking (molecular)EnzymeMoietyStereochemistryMonoamine oxidaseCatalytic cycle

摘要: Monoamine oxidase (MAO) is an enzyme responsible for metabolism of monoamine neurotransmitters which play important role in brain development and function. This exists two isoforms, it has been demonstrated that MAO-B activity, but not MAO-A increases with aging. MAO inhibitors show clinical value because besides the level regulation they reduce formation by-products catalytic cycle, are toxic to brain. A series 2-phenylbenzofuran derivatives was designed, synthesized evaluated against hMAO-A hMAO-B enzymes. bromine substituent introduced 2-phenyl ring, whereas position 5 or 7 benzofuran moiety substituted a methyl group. Most tested compounds inhibited preferentially reversible manner, IC50 values low micro nanomolar range. The 2-(2′-bromophenyl)-5-methylbenzofuran (5) most active compound identified (IC50 = 0.20 μM). In addition, none studied showed cytotoxic activity human neuroblastoma cell line SH-SY5Y. Molecular docking simulations were used explain observed structure–activity relationship this type compounds.

参考文章(40)
G. Cohen, Monoamine oxidase and oxidative stress at dopaminergic synapses Journal of Neural Transmission-supplement. ,vol. 32, pp. 229- 238 ,(1990) , 10.1007/978-3-7091-9113-2_33
Barbara Wendt, Huy Riem Ha, Manfred Hesse, Synthesis of Two Metabolites of the Antiarrythmicum Amiodarone Helvetica Chimica Acta. ,vol. 85, pp. 2990- 3001 ,(2002) , 10.1002/1522-2675(200209)85:9<2990::AID-HLCA2990>3.0.CO;2-R
Yongsheng Yuan, Qing Tong, Li Zhang, Siming Jiang, Hong Zhou, Rui Zhang, Shu Zhang, Qinrong Xu, Daqian Li, Xiaobin Zhou, Jian Ding, Kezhong Zhang, Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients. International Journal of Neuroscience. ,vol. 126, pp. 641- 646 ,(2015) , 10.3109/00207454.2015.1054031
Lesetja Legoabe, Adriaan Van Dyk, Anél Petzer, Jacobus Petzer, 3-Coumaranone derivatives as inhibitors of monoamine oxidase Drug Design Development and Therapy. ,vol. 9, pp. 5479- 5489 ,(2015) , 10.2147/DDDT.S89961
C. J. Fowler, �. Wiberg, L. Oreland, J. Marcusson, B. Winblad, The effect of age on the activity and molecular properties of human brain monoamine oxidase Journal of Neural Transmission. ,vol. 49, pp. 1- 20 ,(1980) , 10.1007/BF01249185
Matilde Yáñez, Nuria Fraiz, Ernesto Cano, Francisco Orallo, Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochemical and Biophysical Research Communications. ,vol. 344, pp. 688- 695 ,(2006) , 10.1016/J.BBRC.2006.03.190
Giovanna L. Delogu, Silvia Serra, Elias Quezada, Eugenio Uriarte, Santiago Vilar, Nicholas P. Tatonetti, Dolores Viña, Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins. ChemMedChem. ,vol. 9, pp. 1672- 1676 ,(2014) , 10.1002/CMDC.201402010
Yuanbin Liu, Daniel A. Peterson, Hideo Kimura, David Schubert, Mechanism of Cellular 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Reduction Journal of Neurochemistry. ,vol. 69, pp. 581- 593 ,(2002) , 10.1046/J.1471-4159.1997.69020581.X